Annual general meeting of Otsuka Pakistan Limited to be held on October 27, 2021

General

Karachi, Otsuka Pakistan Limited informed Pakistan Stock Exchange that annual general meeting of the company is scheduled to be held on October 27, 2021 at Karachi.

The agenda of the meeting will be to receive, consider and adopt the Annual Audited Financial Statements of the Company for the year ended June 30, 2021 together with the Directors and Auditors Reports thereon, to appoint auditors for the year ending June 30, 2022 and fix their remuneration and to transact any other business with the permission of the chair, to approve the final cash dividend of PKR 1.50 i.e 15%.

Further, the closed period of the company is from October 21, 2021 to October 27, 2021 (both days inclusive).

Otsuka Pakistan Limited was incorporated in Pakistan as a public limited company and commenced commercial production of Intravenous Solutions in September 1989 at its factory in Hub, Baluchistan.

The Company is engaged in the manufacturing, marketing and distribution of intravenous infusions and trading in pharmaceutical products, nutritional foods and medical equipment. The Company is an indirect subsidiary of Otsuka Pharmaceutical Company Limited, Japan. Therapeutic Drugs are Otsuka Pakistan’s second line of business; currently consist of Pletaal and Mucosta which are being imported in finished form from Korea.

The total numbers of shares are 12,100,000. The Earnings per share is 7.53 in 2020 which was (14.49) in 2019. The Profit after Taxation is 91,066,000 in 2020 which was 175,348,000 in 2019.